Viewing Study NCT02982668


Ignite Creation Date: 2025-12-24 @ 6:28 PM
Ignite Modification Date: 2026-02-24 @ 8:27 AM
Study NCT ID: NCT02982668
Status: TERMINATED
Last Update Posted: 2021-11-04
First Post: 2016-11-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Optimizing Early Enteral Nutrition in Severe Stroke
Sponsor: Xijing Hospital
Organization:

Study Overview

Official Title: A Multi-center Randomised Controlled Trial to Explore the Ideal Initial Enteral Feeding Strategies in Patients With Severe Stroke at Acute Stage
Status: TERMINATED
Status Verified Date: 2020-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Significantly higher mortality
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: OPENS
Brief Summary: The purpose of this academic lead study is to explore the ideal nutritional support strategy for patient with acute severe stroke.
Detailed Description: Of high mortality and morbidity, severe stroke is associated with devastating damages in neurologic, respiratory, circulatory and many other systems. The outcomes of patients with severe stroke depend largely on medical strategies on acute stage, especially on nutritional support management. Unfortunately, clinical evidence are sparse and the ideal initial feeding strategy remains disputable.

The IF-STROKE study aims to provide reliable data on the effects of modified full enteral feeding (target recruitment 200) and permissive underfeeding in patients with acute severe stroke (target recruitment 200) compared to full enteral feeding (target recruitment 200). Patients presenting with acute (\<72h) severe stroke (GCS ≦ 12 or NIHSS ≧ 11) and dysphagia (defined by Water Swallowing Test) will be randomly assigned to full enteral feeding, modified full enteral feeding, or permissive underfeeding treatment for 7 days.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: